Introduction
============

Paediatric tuberculosis can be controlled or cured if timely and appropriate treatment is completed.[@R1]^,^[@R2] More than 75% of affected patients live in low- and middle-income countries in Asia and Africa and have substantial tuberculosis --related morbidity and mortality.[@R2] Up to 20% of children with tuberculosis in low- and middle-income countries fail to complete treatment.[@R3]

Interrupted tuberculosis treatment poses a public health challenge because it permits the development of drug-resistant disease and allows patients to remain infectious for a relatively long time. Poor adherence results in disease progression, morbidity and death. The most extreme form of incomplete treatment is known as treatment abandonment or treatment default. For tuberculosis, such abandonment is generally represented by a break in treatment of at least two consecutive months.[@R1]

The barriers to treatment completion in low- and middle-income countries include medical expenses, the indirect costs of transportation and time away from work, the stigmas associated with the illness and/or the treatment, communication breakdowns between providers and patients, limited health literacy, the presence of too few health workers and problems in drug procurement.[@R2] We conducted a systematic review and meta-analysis of interventions designed to reduce such barriers to treatment completion among children with tuberculosis in low- and middle-income countries. Our main aim was to appraise the design, delivery and impact of such interventions in such a vulnerable population.

Methods
=======

Search and selection
--------------------

Using a registered protocol (PROSPERO: CRD42013005800), we searched the PubMed and Cochrane databases for relevant publications that had been published between 1 January 2003 and 1 December 2013. Grey literature was hand-searched. Until 1 May 2014, we attempted to contact the authors of relevant articles and other researchers with experience of tuberculosis in low- and middle-income countries. The search strategy ([Box 1](#B1){ref-type="boxed-text"}; available at: <http://www.who.int/bulletin/volumes/93/10/14-147231>) was piloted by two researchers and reviewed by two medical librarians.

###### Search strategy to identify studies on interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries

("low income economies" OR "lower middle income economies" OR "middle income economies" OR "developing countries"\[MeSH Terms\] OR ("developing"\[All Fields\] AND "countries"\[All Fields\]) OR "developing countries"\[All Fields\]) OR ("developing countries"\[MeSH Terms\] OR ("developing"\[All Fields\] AND "countries"\[All Fields\]) OR "developing countries"\[All Fields\] OR ("developing"\[All Fields\] AND "country"\[All Fields\]) OR "developing country"\[All Fields\]) OR ("developing countries"\[MeSH Terms\] OR ("developing"\[All Fields\] AND "countries"\[All Fields\]) OR "developing countries"\[All Fields\] OR ("underdeveloped"\[All Fields\] AND "countries"\[All Fields\]) OR "underdeveloped countries"\[All Fields\]) OR ("developing countries"\[MeSH Terms\] OR ("developing"\[All Fields\] AND "countries"\[All Fields\]) OR "developing countries"\[All Fields\] OR ("underdeveloped"\[All Fields\] AND "country"\[All Fields\]) OR "underdeveloped country"\[All Fields\]) OR (emergent\[All Fields\] AND countries\[All Fields\]) OR (emergent\[All Fields\] AND country\[All Fields\]) OR ("developing countries"\[MeSH Terms\] OR ("developing"\[All Fields\] AND "countries"\[All Fields\]) OR "developing countries"\[All Fields\] OR ("developing"\[All Fields\] AND "nation"\[All Fields\]) OR "developing nation"\[All Fields\]) OR (underdeveloped\[All Fields\] AND "nation"\[All Fields\])) OR (emergent\[All Fields\] AND "nation"\[All Fields\]) OR (("poverty"\[MeSH Terms\] OR "poverty"\[All Fields\] OR ("low"\[All Fields\] AND "income"\[All Fields\]) OR "low income"\[All Fields\]) AND countries\[All Fields\]) OR (("poverty"\[MeSH Terms\] OR "poverty"\[All Fields\] OR ("low"\[All Fields\] AND "income"\[All Fields\]) OR "low income"\[All Fields\]) AND country\[All Fields\]) OR angola OR Fij OR palau OR albania OR gabon OR panama OR algeria OR grenada OR peru OR american samoa OR hungary OR romania OR argentina OR iran OR serbia OR azerbaijan OR iraq OR seychelles OR belarus OR jamaica OR south africa OR belize OR jordan OR st. lucia OR bosnia and herzegovina OR kazakhstan OR st. vincent and the grenadines OR botswana OR lebanon OR suriname OR brazil OR libya OR thailand OR bulgaria OR macedonia, fyr OR tonga OR china OR malaysia OR tunisia OR colombia OR maldives OR turkey OR costa rica OR marshall islands OR turkmenistan OR cuba OR mauritius OR tuvalu OR dominica OR mexico OR venezuela, rb OR dominican republic OR montenegro OR ecuador OR namibia OR armenia OR india OR samoa OR bhutan OR kiribati OR sao tome and principe OR bolivia OR kosovo OR senegal OR cameroon OR Lao OR solomon islands OR cape verde OR lesotho OR sri lanka OR congo OR mauritania OR sudan OR cote d\'ivoire OR ivory coast OR micronesia OR swaziland OR djibouti OR moldova OR syria OR egypt OR mongolia OR timor OR el salvador OR morocco OR ukraine OR georgia OR nicaragua OR uzbekistan OR ghana OR nigeria OR vanuatu OR guatemala OR pakistan OR vietnam OR guyana OR papua new guinea OR west bank OR gaza OR honduras OR paraguay OR yemen OR indonesia OR philippines OR zambia OR afghanistan OR gambia OR myanmar OR bangladesh OR guinea OR nepal OR benin OR niger OR burkina faso OR haiti OR rwanda OR burundi OR kenya OR sierra leone OR cambodia OR korea OR somalia OR central african republic OR kyrgyz OR sudan OR chad OR liberia OR tajikistan OR comoros OR madagascar OR tanzania OR congo OR malawi OR togo OR eritrea OR mali OR uganda OR ethiopia OR mozambique OR zimbabwe)) AND tuberculosis\[MeSH Major Topic\] AND ("Health Education"\[Mesh\] OR "Counseling"\[Mesh\] OR "Directive Counseling"\[Mesh\] OR "Health Promotion"\[Mesh\] OR "Reminder Systems"\[Mesh\] OR "Directly Observed Therapy"\[Mesh\] OR "Social Support"\[Mesh\] OR "Contracts"\[Mesh\] OR "Decision Support Techniques"\[Mesh\] OR intervention OR treatment OR outcome) AND (study OR trial) AND ("Treatment Refusal"\[Mesh\] OR "Patient Participation"\[Mesh\] OR "Patient Dropouts"\[Mesh\] OR "Patient Compliance"\[Mesh\] OR "Motivation"\[Mesh\] OR "Cooperative Behavior"\[Mesh\]) OR "Refusal to Treat"\[Mesh\]) OR "Medication Adherence"\[Mesh\] OR medication adherence OR nonadherence OR non-adherence OR compliance OR noncompliance OR abandonment of treatment OR abandonment of therapy OR treatment abandonment OR therapy abandonment OR treatment default OR lost to follow-up OR loss to follow up OR default\* OR against medical advice OR abscond\* OR refusal OR stop\* treatment OR (interrupt\* AND treatment) OR (treatment AND discontinu\*) OR (treatment AND continu\*) OR failure to complete treatment OR incomplete treatment OR treatment maintenance OR no show OR retention of care OR run away OR attrition)) AND ("last 10 years"\[PDat\] AND Humans\[Mesh\] AND (infant\[MeSH\] OR child\[MeSH\] OR adolescent\[MeSH\] OR "young adult"\[MeSH\]) NOT "case reports"\[Publication Type\]) NOT "review"\[Publication Type\]

To be included in our analyses, a study had to have participants with active tuberculosis who were younger than 20 years and lived in a country that, according to the World Bank, was low-income or middle-income in December 2013. Studies with adult participants were included only if the cohort outcomes for participants younger than 20 years were available. We were only interested in studies on interventions targeted at the improvement of treatment initiation or completion, the improvement of adherence to medications or appointments, the prevention of treatment refusal or adherence surrogates such as self-efficacy or enablement.

Included studies required a control or comparison population. Retrospective or contemporaneous comparisons from the same region were accepted if the between-population similarities and differences were clearly stated. No language, follow-up or study quality restrictions were imposed.

Data extraction
---------------

By using standardized forms, two investigators independently screened abstracts and extracted data. Discrepancies between the two investigators were resolved through discussion (16 records) or by the seeking of clarification from an author of an article of potential interest (three records).

We detected 62 studies that met all of our eligibility criteria apart from the provision of explicit outcomes for paediatric patients. Although we attempted to determine such outcomes by contacting the authors of the corresponding study reports, we successfully obtained outcomes for just 10 additional studies. The other 52 reports provided no current contact information for any author (14 studies), had authors who did not reply to our queries (20 studies) or had authors who stated that the data we wanted were not available (18 studies).

From each eligible report, we extracted information on methods, interventions, outcomes, participants, settings and co-infection with human immunodeficiency virus (HIV). Treatment outcomes were extracted according to the World Health Organization's (WHO's) classifications, with treatment success defined as completion or cure[@R1] -- as given in the reports.

Risk of bias in the randomized trials was assessed using the Cochrane Assessment tool[@R4] and reported according to CONSORT standards.[@R5] Quality of the non-randomized trials was assessed using the Effective Public Health Practice Project Quality Assessment tool[@R6] and reported according to TREND standards.[@R5]^,^[@R7] Funding source was recorded as a possible bias source. Studies that integrated qualitative data were assessed using the relevant tools of the Critical Appraisal Skills programme.[@R8] Reporting of the systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.[@R9]

Interventions to improve treatment adherence among paediatric patients of tuberculosis were summarized through independent iterative re-reading and organization of the identified themes -- with discussion to achieve consensus -- in alignment with WHO's adherence dimensions for long-term therapies.[@R2] For the initial data extraction, interventions were divided into five categories: education, psychosocial, care delivery, health systems and social protection or financial ([Table 1](#T1){ref-type="table"}). We attempted to determine those factors that promoted or threatened treatment completion. These factors might be related to: (i) the patient -- e.g. literacy, (ii) the condition, including the presence of comorbidities, (iii) the therapy, including cultural lay beliefs, (iv) the health system, including accessibility, and (v) socioeconomic status, including family income.

###### Categorization of interventions aimed at improving tuberculosis treatment adherence

  Intervention category                                                                  Components                                          Examples
  -------------------------------------------------------------------------------------- --------------------------------------------------- -----------------------------------------------------------------------------------
  Education                                                                              Behavioural and cognitive                           Teaching of patients, family members and community members
  Psychosocial                                                                           Behavioural and affective                           Counselling
  Contracts                                                                                                                                  
  Cultural competence contextualization                                                                                                      
  Social support to include communication relevant to patient efficacy or enablement                                                         
  Care delivery                                                                          Behavioural, affective, biological and structural   Treatment regimen interventions in the form of combination pills or easier dosing
  Convenience of visits timed with medication refills                                                                                        
  Staff training -- including provider-targeted interventions related to communication                                                       
  Decentralization of health contact via home visits or community health workers                                                             
  Health systems                                                                         Behavioural, biological, cognitive and structural   Management processes
  Tracer systems                                                                                                                             
  Referral support                                                                                                                           
  Direct accountability in the form of direct observation of therapy                                                                         
  Social protection or financial                                                         Behavioural and structural                          Financial support for -- or provision of -- food, transportation and housing
  Free health services or reimbursement of costs                                                                                             

Statistical analysis
--------------------

We did a meta-analysis of the treatment success rates recorded among paediatric patients. We used the Mantel-Haenszel model and the DerSimonian and Laird random-effects method to calculate odds ratios (ORs) and their 95% confidence intervals (CIs) from the unadjusted raw data, with the assumption that intervention effects on treatment success in one setting might differ from those in other settings. We did sensitivity analyses that included only randomized or quasi-randomized studies or excluded studies with comparison population estimates derived from another setting (available from the corresponding author). Heterogeneity across studies was assessed using the *I^2^* statistic. We summarized the main meta-analysis results as a forest plot but used funnel plots to assess publication bias. Analyses were conducted using Review Manager version 5.2 (Cochrane Collaboration, Copenhagen, Denmark).

Results
=======

We initially identified 413 articles of potential interest. Of these, 164 qualified for full-text review and we included 15 articles in our qualitative synthesis ([Fig. 1](#F1){ref-type="fig"}).[@R10]^--^[@R24] The articles were on 15 separate studies ([Table 2](#T2){ref-type="table"}). Three of the studies were published in Portuguese[@R11]^,^[@R13]^,^[@R14] and the remainder in English. Five studies were based in the upper-middle-income countries of Brazil[@R11]^,^[@R13]^,^[@R14] and Thailand,[@R15]^,^[@R16] three in the lower-middle-income countries of India,[@R12] Lesotho[@R10] and Pakistan,[@R17] and seven in the low-income countries of Bangladesh,[@R23] Ethiopia,[@R18]^,^[@R19] Kenya,[@R22] Myanmar,[@R24] South Sudan[@R21] and the United Republic of Tanzania.[@R20] Four settings were urban outpatient,[@R11]^,^[@R13]^,^[@R16]^,^[@R17] three rural outpatient,[@R12]^,^[@R18]^,^[@R19] two suburban outpatient,[@R23]^,^[@R24] one rural camp.[@R21] The remaining studies were done in variable settings.[@R10]^,^[@R14]^,^[@R15]^,^[@R20]^,^[@R22]

![Flowchart for the selection of studies on interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries](BLT.14.147231-F1){#F1}

###### Studies on interventions to improve treatment adherence for paediatric tuberculosis in low- and middle-income countries, 1996--2011

  Study                                Country and study design                                             Care setting                                                                                                                      Participant description                                                                                                                                                                                                                           Duration, months   Period                      Study arms                                                                                                                                                                                                                                                                    
  ------------------------------------ -------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ --------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Non-randomized**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Anuwatnonthakate et al.[@R15]        Thailand, prospective observational cohort^a^                        Region -- all public and private facilities in four provinces                                                                     Diverse patient population including urban, rural and migrant populations. HIV co-infection rate 20%. Of the participants, 223 (3%) were aged \< 15 years^b^.                                                                                     24                 2004--2006                  DOT supervised by family member or HCW                                                                                                                                                                                                                                        Self-administered therapy
  Heck et al.[@R11]                    Brazil, retrospective observational cross-sectional^a^               City -- 18 urban outpatient primary health units and five referral units supervised by Municipal Tuberculosis Control Programme   Socioeconomic and education summary not provided; HIV co-infection rate 16%. Of the participants, 57 (9%) were aged ≤ 19 years.                                                                                                                   96                 2000--2004 and 2005--2008   Decentralization of tuberculosis programme actions for primary care and implementation of DOT                                                                                                                                                                                 SOC before decentralization initiatives
  Lee et al.[@R23]                     Bangladesh, prospective before-and-after study^a^                    Clinic -- suburban primary health clinic in industrial complex near capital                                                       Participants had low socioeconomic status, limited education and high level of illiteracy. Of the participants, 26 (7%) were aged \< 18 years^b^.                                                                                                 33                 2005--2006 and 2006--2007   Patient education on the importance of treatment adherence provided, by a physician, weekly for 1 month, fortnightly for next month, then monthly. Visits scheduled to coincide with medication refills                                                                       SOC, with no standardized patient education and return visits not timed to coincide with refills
  Marques and da Cunha[@R14]           Brazil, retrospective before-and-after^a^                            Hospital -- urban hospital                                                                                                        Indigenous population suffering extreme poverty, malnutrition and cultural and socioeconomic barriers to extended hospitalization. Of the participants, 244 (41%) were aged \< 15 years^b^.                                                       35                 1996--1998 and 1998--1999   Outpatient treatment with home-based DOT via indigenous health agents                                                                                                                                                                                                         Systematic hospitalization of patients for up to 6 months
  Ong'ang'o et al.[@R22]               Kenya, retrospective cohort^a^                                       Region -- sample of four urban and rural public health facilities, using and not using CHWs                                       Mention of stigma towards tuberculosis and cultural beliefs against conventional treatment of the disease in rural setting. Of the participants, 298 (11%) were aged \< 14 years^b^.                                                              72                 2005--2011                  Personalized education from CHW, on treatment and risks involved in lack of adherence, plus CHW-supervised DOT at household level with ongoing CHW educational support                                                                                                        Nurse at health facility advised patients of treatment schedule, need for adherence and need for family support. Weekly DOT at health facility
  Satti et al.[@R10]                   Lesotho, retrospective cohort                                        Community -- mountainous rural and urban, inpatient and outpatient setting                                                        Nineteen patients with suspected or confirmed MDR tuberculosis, of whom 14 (74%) were co-infected with HIV, 12 (63%) were malnourished and all were aged \< 16 years.                                                                             42                 2007--2011                  Comprehensive approach to care for MDR tuberculosis, with or without HIV co-infection, using social support, close monitoring by CHWs and clinicians and inpatient care when warranted                                                                                        Patients of MDR tuberculosis with high rates of HIV co-infection in neighbouring South Africa
  van den Boogaard et al.[@R20]        United Republic of Tanzania, retrospective observational cohort^a^   Region -- urban and rural districts with national referral hospital, regional hospital and primary health clinics                 Socioeconomic and education summary not provided. HIV co-infection rate 31%. Of the participants, 308 (11%) were aged \< 15 years.                                                                                                                12                 2007                        Patient-centred treatment that allowed patients to choose between community and facility-based DOT                                                                                                                                                                            Conventional facility-based DOT supervised by facility-based provider
  Badar et al.[@R17]                   Pakistan, prospective observational cohort                           Province -- urban, nongovernment outpatient tertiary care hospital as referring centre                                            Socioeconomic and education summary not provided. Of the participants, 150 (34%) were aged ≤ 19 years.                                                                                                                                            9                  2009                        Electronic database register, designated oversight of referrals, staff referral orientation, tracking via 1--3 phone calls, communication between centres via exchanges of pre-stamped mail, scheduled meetings and phone contact and patients referred to closest facility   Patient responsible for return to referring unit
  Cantalice Filho[@R13]                Brazil, before-and-after^a^                                          Clinic -- urban primary health care outpatient clinic                                                                             Socioeconomic and education summary not provided. HIV co-infection rate \< 5%. Of the participants, 8 (6%) were aged \< 18 years^b^.                                                                                                              57                 2001--2003 and 2004--2006   Standard treatment regimen plus monthly food basket                                                                                                                                                                                                                           Standard treatment regimen, including self-administered therapy
  Keus et al.[@R21]                    South Sudan, prospective observational cohort^a^                     Programme -- humanitarian rural tuberculosis camp located in "transitional" zone between militia and local factions               Pastoral, migratory population living in conflict conditions with no health infrastructure. HIV co-infection rate \< 5%. Of the participants, 84 (52%) were aged \< 15 years.                                                                     9                  2001                        Village-based treatment in a conflict zone of South Sudan                                                                                                                                                                                                                     Treatment in a less insecure area -- Manyatta Region -- with 2-month supervised then 3-month unsupervised regimen
  Lönnroth et al.[@R24]                Myanmar, prospective cohort                                          Clinics -- multiple township outpatient clinics serving low-income population                                                     Mostly patients with low socioeconomic status, from townships in which many used private health care as the first point of contact. Of the participants, 66 (26%) were aged 16 years.                                                             14                 2004--2005                  Social franchise engaging private general practitioners to deliver quality controlled tuberculosis care, including service branding, defined treatment supporter and default tracing mechanism                                                                                Continuation of previous SOC, with patient utilization of existing treatment centres and the public sector's DOT logo branding
  **Randomized or quasi-randomized**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Datiko and Lindtjørn[@R18]           Ethiopia, prospective randomized                                     Clinics -- rural outpatient setting in south of country                                                                           Patients with poor access, poverty and low health-seeking behaviours. Of the participants, 32 (10%) were aged \< 14 years.                                                                                                                        19                 2006--2008                  Local treatment by HEWs. HEW training in adherence support, diagnosis, referral with enhanced case finding and the problems of non-adherence. Community mobilization and education                                                                                            HEWs did not receive training on diagnostic techniques or adherence support. HEWs engage in community education on symptoms of tuberculosis. DOT provided at health facility instead of within local neighbourhood
  Demissie et al.[@R19]                Ethiopia, prospective quasi-randomized^a^                            Clinics -- rural outpatient centres in north of country                                                                           Tuberculosis associated with strong community stigma, to the extent that patients may lose their work if employer is aware of diagnosis. Of the participants, 7 (5%) were aged \< 15 years.                                                       12                 1998--1999                  Patients organized according to residential area into clubs, each with 3--10 members, an elected leader and the same appointment dates. Weekly club meetings with emphasis on social support towards treatment completion.                                                    Continuation of previous SOC. No tuberculosis clubs but otherwise similar treatment regimen and packages of health education as in the intervention arm
  Khortwong and Kaewkungwal[@R16]      Thailand, prospective quasi-randomized^a^                            Clinics -- urban outpatient hospital clinics                                                                                      Marginalized migrant population living in crowded conditions, with high mobility. Lack of legal status or registration made most ineligible for routine health-care services. Of the participants, 4 (4%) were aged \< 18 years^b^.               16                 2009--2010                  Migrant population provided with intensive education modules, home and workplace visits and phone-call reminders, with emphasis on therapeutic health team relationships                                                                                                      Migrant population received continuation of previous SOC, which included optional treatment supervision by a village health volunteer
  Mathew et al.[@R12]                  India, retrospective quasi-randomized observational cohort           Clinic -- outpatient clinic based in rural secondary-level mission hospital in north of country                                   In one of the poorest regions in India, with high rate of illiteracy. Tribal population engaged in small-scale farming, with poor road access. Of the participants, 94 (14%) were aged \< 15 years but data were only reported for 61 of these.   30                 2001--2003                  Free drugs, visits made to the patient by the DOT supervisor -- a community member -- monthly during intensive phase and every 2 months thereafter. Adherence checks. Patient asked to visit clinic three times during therapy                                                Drugs provided at cost, family member supported DOT and accompanied patient to appointments. Monthly clinic visits in intensive phase and clinic visits every 2 months thereafter

CHW: community health worker; DOT: directly observed therapy; HCW: health-care worker; HEW: health-extension worker; HIV: human immunodeficiency virus; MDR: multidrug-resistant; SOC: standard of care.

^a^ An author of the relevant article had to be contacted to clarify the rate of treatment success in the paediatric participants and/or the definition used for treatment abandonment.

^b^ The size of the paediatric sample has not been published previously and had to be obtained by direct contact with an author of the relevant article.

The payment system for health services was not described in nine studies[@R11]^,^[@R12]^,^[@R14]^--^[@R20] but the reports on four studies described capped fees[@R24] or clinic fee coverage.[@R16]^,^[@R23]^,^[@R24] In seven studies, drug expenses were covered for one intervention group only,[@R12] for both the intervention and comparison groups, as part of a national scheme,[@R16]^,^[@R22]^--^[@R24] or for at least the intervention group -- with unclear indication if the drug expenses of the comparison group were also covered.[@R10]^,^[@R21]

The included studies were conducted between 1996 and 2011 and reported -- including the unpublished data supplied by authors -- between 2003 and 2014. The median duration of the investigated interventions was 24 months (range: 9--96). The number of participants younger than 20 years -- which had to be clarified through author contact for six studies and excluded population-based comparison samples -- varied from four to 308 (mean: 106; median: 61) and totalled 1587 across all 15 studies. Such paediatric patients represented between 3% and 100% of the patients investigated (mean: 22%; median: 11%). The prevalence of HIV co-infection, which was only reported for six studies, ranged from less than 5% to 74%.[@R10]^,^[@R11]^,^[@R13]^,^[@R15]^,^[@R20]^,^[@R21]

Interventions
-------------

The timing of interventions either included referral[@R10] or induction[@R15] or ran just from treatment initiation to treatment completion.[@R11]^--^[@R14]^,^[@R16]^--^[@R24] Health behaviour models informing intervention design were mentioned in two studies -- the precede-proceed model was used to help engage patients in one study[@R16] while social franchising was used to help engage providers in another study.[@R24]

Many studies involved several categories and subcategories of interventions ([Table 3](#T3){ref-type="table"}). Some used interventions combining cognitive and behavioural components, as exemplified by education for patients,[@R10]^,^[@R12]^,^[@R16]^,^[@R18]^,^[@R19]^,^[@R21]^--^[@R24] family members,[@R10]^,^[@R12]^,^[@R20]^,^[@R21] or community leaders.[@R12]^,^[@R18]^,^[@R19]^,^[@R21]^,^[@R24] Educational curricula addressed the administration[@R11]^,^[@R16]^,^[@R18]^--^[@R20]^,^[@R22]^,^[@R23] and adverse effects of medication,[@R16]^,^[@R19]^,^[@R23]^,^[@R24] the personal or public health consequences of early treatment discontinuation[@R16]^,^[@R19]^,^[@R21]^--^[@R23] and overall health or hygiene.[@R16]^,^[@R18]^,^[@R19]^,^[@R21]

###### Interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries, 1996--2011

  Main category of primary intervention, reference   Intervention categories and subcategories included in study                                                                                                            
  -------------------------------------------------- ------------------------------------------------------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  **Educational**                                                                                                                                                                                                           
  Khortwong and Kaewkungwal[@R16]                    --                                                            \+   --   --   \+   \+   \+   --   \+   \+   --   \+   \+   --   --   \+   --   \+   \+   --   \+   --   --
  Lee et al.[@R23]                                   --                                                            \+   --   --   \+   --   --   --   \+   --   \+   --   --   --   --   --   --   --   --   --   --   --   --
  **Psychosocial**                                                                                                                                                                                                          
  Demissie et al.[@R19]                              --                                                            \+   --   \+   \+   \+   --   \+   \+   --   \+   --   \+   --   --   \+   --   \+   --   --   --   --   --
  **Care delivery**                                                                                                                                                                                                         
  Anuwatnonthakate et al.[@R15]                      --                                                            --   --   --   --   --   --   --   \+   \+   --   \+   --   --   --   \+   --   --   --   --   --   --   --
  Datiko and Lindtjørn[@R18]                         --                                                            \+   --   \+   \+   --   --   --   --   \+   --   \+   \+   \+   \+   \+   --   \+   --   --   --   --   --
  Heck et al.[@R11]                                  --                                                            --   --   --   --   --   --   --   --   --   --   \+   --   --   --   \+   --   --   --   --   --   --   --
  Keus et al.[@R21]                                  \+                                                            \+   \+   \+   \+   \+   \+   \+   \+   --   --   \+   \+   \+   \+   \+   --   \+   \+   --   \+   --   --
  Marques and da Cunha[@R14]                         --                                                            --   --   --   --   \+   --   \+   --   --   --   \+   --   --   --   --   --   --   --   --   --   --   --
  Satti et al.[@R10]                                 --                                                            \+   \+   --   \+   --   \+   --   \+   --   \+   \+   \+   --   \+   \+   --   \+   \+   \+   \+   \+   --
  van den Boogaard et al.[@R20]                      \+                                                            --   \+   --   --   --   --   --   \+   \+   --   \+   --   --   --   \+   --   --   --   --   --   --   --
  **Health systems**                                                                                                                                                                                                        
  Badar et al.[@R17]                                 --                                                            --   --   --   --   --   --   --   --   --   --   --   \+   --   --   --   \+   \+   --   --   --   --   --
  Lönnroth et al.[@R24]                              \+                                                            \+   --   \+   --   --   --   --   --   --   --   --   \+   \+   \+   --   \+   \+   --   --   --   --   \+
  Mathew et al.[@R12]                                --                                                            \+   \+   \+   --   --   --   --   \+   \+   \+   \+   --   \+   \+   \+   --   \+   --   --   --   --   \+
  Ong'ang'o et al.[@R22]                             --                                                            \+   --   --   \+   \+   \+   --   \+   \+   --   \+   \+   --   --   \+   --   \+   --   --   --   --   --
  **Social protection or financial**                                                                                                                                                                                        
  Cantalice Filho[@R13]                              --                                                            --   --   --   --   --   --   --   --   --   --   --   --   --   --   --   --   --   \+   --   --   --   --

^a^ Refers to relationship-building between providers and patients**.**

Eleven studies incorporated affective and behavioural components, through psychosocial support with therapeutic alliances (i.e. relationship-building between providers and patients),[@R10]^,^[@R16]^,^[@R18]^,^[@R19]^,^[@R21]^--^[@R23] patient empowerment to select a treatment supporter or location,[@R12]^,^[@R15]^,^[@R16]^,^[@R18]^,^[@R20]^,^[@R22] counselling,[@R10]^,^[@R16]^,^[@R21]^,^[@R22] problem-solving,[@R16] decreasing stigma[@R14]^,^[@R19]^,^[@R21] and peer support.[@R14]^,^[@R16]^,^[@R19]^,^[@R21]^,^[@R22]

Care delivery interventions included health provider training,[@R10]^,^[@R16]^--^[@R19]^,^[@R21]^,^[@R22]^,^[@R24] convenient appointment scheduling,[@R10]^,^[@R12]^,^[@R19]^,^[@R23] migration-sensitive therapy duration[@R21] and easier dosing schedules.[@R10]^,^[@R12]^,^[@R18]^,^[@R24] Health system interventions included the directly observed treatment, short-course strategy,[@R10]^--^[@R12]^,^[@R15]^,^[@R16]^,^[@R18]^--^[@R22] referral support,[@R17]^,^[@R19] patient tracers[@R10]^,^[@R12]^,^[@R16]^--^[@R19]^,^[@R21]^,^[@R22]^,^[@R24] -- including tracing within 24 hours[@R12]^,^[@R21] -- and home visiting.[@R16]^,^[@R22]

Social protection or financial support interventions included weekly food rations,[@R10]^,^[@R21] monthly food baskets,[@R13] housing,[@R21] medication coverage,[@R12]^,^[@R21] recognition of the importance of employment[@R14]^,^[@R16] or school,[@R10] essential supplies for daily life,[@R16] transport reimbursement[@R10] and income-generation support.[@R10] One study required a deposit that was refundable upon treatment completion.[@R12]

Treatment adherence
-------------------

Adherence-related measures included those extracted from self-reports,[@R16]^,^[@R24] pharmacy refill data,[@R23] medication records maintained by treatment supporters,[@R12]^,^[@R19] clinic attendance records,[@R23] confirmation of referrals[@R17] and medical records.[@R10]^,^[@R11]^,^[@R13]^--^[@R15]^,^[@R18]^,^[@R20]^--^[@R22]^,^[@R24]

Terminology describing unfavourable outcomes included default,[@R10]^,^[@R12]^,^[@R15]^,^[@R16]^,^[@R18]^--^[@R22]^,^[@R24] drop-out,[@R11]^,^[@R14] abandonment[@R13]^,^[@R14] and treatment interruption.[@R19] Three of 10 studies used the term default and, in defining their default criteria, were consistent with WHO definitions.[@R10]^,^[@R19]^,^[@R24] Drop-out was defined in one study as treatment interruption for more than 30 days.[@R11] Treatment abandonment was not defined in the two studies using the term.[@R13]^,^[@R14]

In addition to treatment success -- i.e. completion or cure -- positive outcomes were defined in the study reports as successful referral -- i.e. confirmed arrival at the referral facility,[@R17] continuous attendance at scheduled visits,[@R22]^,^[@R23] more than 90% medication adherence[@R23] or self-reported beneficial health behaviours.[@R16]

Risk of bias
------------

The benefits of the investigated interventions may be overestimated because of short follow-up and failure to assess adherence after the interventions were discontinued. Confounders, such as the extra attention given to participants during educational interventions,[@R16]^,^[@R23] complicate our analyses. Although one study report details how controls -- who did not receive the educational intervention -- were supervised by health volunteers,[@R16] it failed to give any idea of the corresponding contact time. The concurrent use of several interventions makes it hard to determine the main reason for successful outcomes. Social feedback loops -- in which successful interventions foster a dynamic for more community adherence -- were subjectively recognized by several research teams.[@R16]^,^[@R18]^,^[@R19]^,^[@R21]^,^[@R24] Intervention complexity increased as attention expanded beyond the patient to include the provider,[@R23] the family,[@R13]^--^[@R15] both the provider and family[@R10]^--^[@R12]^,^[@R16]^,^[@R17]^,^[@R20] or the provider, family and community.[@R18]^,^[@R19]^,^[@R21]^,^[@R22]^,^[@R24] Complexity was characterized by contextual interactions that were susceptible to policy timing,[@R13]^,^[@R18]^,^[@R20]^,^[@R21]^,^[@R24] staffing capabilities and attitudes,[@R12]^,^[@R16]^,^[@R17]^,^[@R19]^,^[@R22]^,^[@R23] relationships[@R13]^,^[@R16]^,^[@R19]^,^[@R23] and resources.[@R18]^,^[@R19]^,^[@R23]^,^[@R24] No empiric quality measures of implementation fidelity were described.

Two studies incorporated qualitative data from focus groups and in-depth interviews.[@R19]^,^[@R22] Although context, sampling and data collection were outlined and the findings appeared supported by data, there was no discussion of reflexivity and no detailed description of the analyses. None of the studies we investigated incorporated long-term observational or ethnographic approaches.

In one prospective randomized controlled trial, the study communities were randomly allocated to intervention and control groups to limit selection bias.[@R18] Three quasi-randomized trials determined assignment by residence.[@R12]^,^[@R16]^,^[@R19] No before-and-after studies used controls to account for any secular change. None of the articles described blinding measures and three specified a lack of blinding for assessors[@R11]^,^[@R24] or participants.[@R20]

All of the results reported in thirteen studies were apparently defined a priori.[@R10]^--^[@R16]^,^[@R18]^--^[@R20]^,^[@R22]^--^[@R24] The remaining two studies accounted for modification of the results reported due to limited follow-up data, which had impaired the assessment of cure[@R21] or treatment outcome beyond referrals.[@R17]

Funding sources included nongovernmental organizations,[@R10]^,^[@R11]^,^[@R20]^--^[@R24] health departments[@R18] or international[@R15]^,^[@R17]^,^[@R19] or local[@R16] academic institutes or were not specified.[@R11]

[Table 4](#T4){ref-type="table"} and [Table 5](#T5){ref-type="table"} show the results on study-specific biases (available at: <http://www.who.int/bulletin/volumes/93/10/14-147231>).

###### Assessment of non-randomized studies on interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries

  Study                           Selection bias   Study design   Confounders   Blinding    Data collection method   Withdrawals and dropouts   Global rating
  ------------------------------- ---------------- -------------- ------------- ----------- ------------------------ -------------------------- ---------------
  Anuwatnonthakate et al.[@R15]   Moderate         Moderate       Strong        Weak        Weak                     Strong                     Weak
  Heck et al.[@R11]               Moderate         Weak           Weak          Weak        Weak                     Moderate                   Weak
  Lee et al.[@R23]                Moderate         Moderate       Strong        Not clear   Weak                     Moderate                   Moderate
  Marques and da Cunha[@R14]      Not clear        Moderate       Weak          Not clear   Weak                     Weak                       Weak
  Ong'ang'o et al.[@R22]          Moderate         Moderate       Strong        Moderate    Weak                     Strong                     Moderate
  Satti et al.[@R10]              Moderate         Weak           Weak          Not clear   Weak                     Strong                     Weak
  van den Boogaard et al.[@R20]   Moderate         Moderate       Moderate      Weak        Weak                     Moderate                   Weak
  Badar et al.[@R17]              Not clear        Weak           Weak          Weak        Weak                     Weak                       Weak
  Cantalice Filho[@R13]           Moderate         Moderate       Moderate      Not clear   Weak                     Weak                       Weak
  Keus et al.[@R21]               Moderate         Weak           Weak          Moderate    Weak                     Strong                     Weak
  Lönnroth et al.[@R24]           Weak             Weak           Weak          Not clear   Weak                     Strong                     Weak

Note: Assessed by using Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies.

###### Risk of bias in randomized control and quasi-randomized control studies on interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries

  Study                             Random sequence generation   Allocation concealment   Blinding of participants and personnel   Blinding of outcome assessors   Incomplete outcome data   Selective reporting   Other bias
  --------------------------------- ---------------------------- ------------------------ ---------------------------------------- ------------------------------- ------------------------- --------------------- ------------
  Datiko and Lindtjørn[@R18]        Low                          High                     Low                                      High                            Low                       Low                   Low
  Demissie et al.[@R19]             High                         Unclear                  Unclear                                  High                            Low                       Unclear               Low
  Khortwong and Kaewkungwal[@R16]   High                         Unclear                  Unclear                                  High                            Low                       Unclear               Low
  Mathew et al.[@R12]               High                         Unclear                  High                                     High                            High                      Unclear               Low

Note: Assessed by using Cochrane criteria for judging risk of bias.[@R25]

Meta-analysis
-------------

Treatment success rates for the paediatric participants in both the treatment and comparison groups were reported for 11 studies.[@R10]^--^[@R12]^,^[@R14]^--^[@R16]^,^[@R18]^--^[@R20]^,^[@R22]^,^[@R23] These studies were included in the meta-analysis and together represented 1279 children -- excluding those in any external comparison groups. In three of the four studies excluded from the meta-analysis, the interventions investigated appeared to bring improved rates of treatment success, for all age groups.[@R13]^,^[@R21]^,^[@R24] The results of the other excluded study[@R17] indicated that the intervention led to increased referral rates.

Meta-analysis revealed a threefold improvement in odds of treatment success for children receiving the interventions ([Fig. 2](#F2){ref-type="fig"}; OR: 3.02; 95% CI: 2.19--4.15). There was no evidence of statistical heterogeneity (*I^2^*: 0%). A funnel plot showed symmetry for the large, high-powered studies but potential publication bias for the smaller studies ([Fig. 3](#F3){ref-type="fig"}; available at: <http://www.who.int/bulletin/volumes/93/09/14-147231>). Sensitivity analysis did not modify the overall results (available from the corresponding author). Baseline risk factors reported for poor adherence outcomes are outlined in [Box 2](#B2){ref-type="boxed-text"}.
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###### Reported risk factors for poor tuberculosis treatment adherence outcomes in paediatric patients

### Patient-related

-   Female sex[@R12]

-   Male sex[@R14]^,^[@R23]

### Condition-related

-   Human immunodeficiency virus-positive[@R20]

-   Smear-negative tuberculosis[@R20]^,^[@R23]

### Treatment-related

-   Tuberculosis retreatment[@R24]

### Social and/or economic related

-   Low-socioeconomic level[@R24]

### Health system related

-   Distance from care source[@R12]

Discussion
==========

In our review of interventions to promote paediatric tuberculosis treatment adherence in low- and middle-income countries, we found evidence that such interventions can result in clinically important improvements in tuberculosis treatment success. Diverse interventions addressing education, psychosocial support, care delivery, health system strengthening and social protection are reportedly feasible and effective in facilitating treatment completion.

Several studies followed collaborative strategies. For example, there was evidence of social franchise programmes communicating with the media, tuberculosis villages communicating with local leaders, tuberculosis clubs communicating with neighbours, health centres communicating with referral facilities and health providers engaging in motivational communication with patients.

We used systematic methods to identify and analyse a broad range of studies, without language limitations and with solicitation of input from the authors of relevant articles in an attempt to minimize search bias. We provided detailed descriptions and syntheses of interventions -- which were often multi-component and complex -- that had been implemented among children in low- and middle-income countries. Our summary findings may help guide future intervention planning and evaluation. Our reviews did, however, have several limitations. For example, few studies included specific details on the nature of their paediatric programme, and no data on individual patients were available. Given the generally small sample sizes, the reported confidence intervals for the effects of individual interventions were often broad. Despite this, all but one of the 11 studies included in the meta-analysis had odds ratios that indicated that the investigated intervention improved the rate of treatment success, and the four largest of these studies provided unequivocal evidence of such benefit.

Heterogeneity in the context and measurement of adherence, outcome definition and reporting limit the value of between-study comparisons. In high-income countries, multi-component interventions are common and often found to be superior to single-component interventions.[@R26] Several of the relevant studies included in our reviews also attempted to target several adherence factors simultaneously, by using complex interventions. Such complex interventions make it difficult to attribute the results to particular intervention categories or components. One of the studies we reviewed was of an intervention that included education, improved dosing and appointment convenience, patient tracing, reduction of out-of-pocket costs and a deposit that was refunded on treatment completion.[@R12] It may be that only when implemented together do these elements succeed.

Recognizing the interconnected nature of WHO's five adherence dimensions and intervention categories for long-term therapies,[@R2] we have summarized contextual factors affecting the adherence interventions we investigated in a framework ([Fig. 4](#F4){ref-type="fig"}). The themes highlighted in this figure are intended to be illustrative across dimensions and intervention categories. For instance, factors that may adversely affect tuberculosis treatment adherence that span psychosocial and educational categories -- e.g. low literacy and limited self-efficacy -- are shown in the figure alongside adherence-promoting factors such as family education and patient empowerment. The contextual framework may aid further collaborative studies and analyses of adherence-targeted interventions.
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Through qualitative analysis, we identified three areas where studies described -- or failed to describe -- children's unique features that can affect adherence intervention delivery. First, few studies described paediatric-specific disease epidemiology and use of paediatric-inclusive outcomes. Several authors reported an unexpectedly high prevalence of paediatric tuberculosis that warranted management as a public health problem.[@R14]^,^[@R18]^,^[@R21]However, most of the studies that we screened simply excluded children and 54 studies that would otherwise have been eligible for our analyses had to be excluded because they failed to report paediatric outcomes separately. Even for the eligible studies, adherence outcomes were not explicitly adapted for paediatric patients -- although paediatric-specific treatment toxicity was recognized in one study.[@R10]

Second, several reports noted challenges in paediatric tuberculosis diagnosis and care. Children can pose diagnostic dilemmas that complicate epidemiological and outcome estimates.[@R10]^,^[@R21] One study noted that paediatric lymph-node biopsies could not be safely performed locally.[@R21] Another considered how children's difficulty with sputum production may contribute to low detection rates[@R18] while a different study specified distinct sputum collection techniques for younger children.[@R10] Dosing instructions that were adapted for paediatric treatment were also recommended.[@R10] Key comorbidities in children -- e.g. malnutrition[@R21] -- may benefit from dedicated attention.

Third, several studies acknowledged the need to consider the preferences and social role of children and adolescents, who may need tailored interventions. In one study involving the use of directly observed, short-term treatment, children and women were more likely than men to select community-based over facility-based treatment, when given the option.[@R20] Another study adapted an intervention, for use among children, according to household and social needs. This intervention included supporting the children in returning to school.[@R10] As one study commented, tuberculosis -- and tuberculosis treatment -- can cut the economic productivity of adolescents and young adults, who tend to have relatively high burdens of the disease.[@R12]

Based on our review and identified themes, future studies need to: (i) assess interventions in low- and middle-income countries that explicitly analyse paediatric-inclusive and paediatric-distinct needs and outcomes, (ii) use mixed-method approaches that can assess the pathways linking context-dependent factors with outcomes, (iii) use longitudinal evaluations that investigate the sustainability of the effectiveness and benefits of interventions and the potential burdens posed by interventions, and (iv) incorporate and address cost--effectiveness, resource implications and potential scalability.

Our findings indicate the potential usefulness of diverse interventions to increase the rate of treatment completion among paediatric tuberculosis patients and improve outcomes in resource-poor settings.
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